230 related articles for article (PubMed ID: 1525790)
1. Comparative in vitro activity of Ro 09-1428, a novel cephalosporin with a catechol moiety.
Qadri SM; Ayub A; Ueno Y; Saldin H
Clin Ther; 1992; 14(4):562-9. PubMed ID: 1525790
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of cefdinir (FK 482, PD 134393, CI-983): a new orally active cephalosporin.
Qadri SM; Ueno Y; Saldin H; Cunha BA
Chemotherapy; 1993; 39(2):112-9. PubMed ID: 8458243
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the in-vitro activity of cefepime and other cephalosporins.
Lim VK; Halijah MY
Malays J Pathol; 1993 Jun; 15(1):65-8. PubMed ID: 8277793
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of cefepime against nosocomial isolates.
Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
Soussy CJ; Le Van Thoi J; Duval JR
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745
[TBL] [Abstract][Full Text] [Related]
8. [Computerized analysis of activity profiles of beta-lactams].
Pitton JS; Philippin JL; Fournier P
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):581-5. PubMed ID: 3937131
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Fass RJ
Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
[TBL] [Abstract][Full Text] [Related]
10. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
Reynaud A; Desnoes M; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
Auckenthaler R; Waldvogel FA
Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
13. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
[TBL] [Abstract][Full Text] [Related]
14. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
Bell JM; Turnidge JD;
Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
[TBL] [Abstract][Full Text] [Related]
16. [Comparative in vitro susceptibility of clinical bacterial isolates to pefloxacin and 14 antibiotics].
Dolna I; Ruczkowska J; Chomontowicz M
Przegl Lek; 1992; 49(7):213-5. PubMed ID: 1297147
[TBL] [Abstract][Full Text] [Related]
17. Comparative antibacterial activity of the aminothiazolyl cephalosporin RU 29,246.
Qadri SM; Ueno Y; Saldin H; Tullo DD; Lee GC
Chemotherapy; 1993; 39(3):175-81. PubMed ID: 8508687
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of Ro 23-9424, a dual-acting cephalosporin-quinolone antimicrobial agent.
Qadri SM; Ueno Y; Saldin H; Cunha BA
J Clin Pharmacol; 1993 Oct; 33(10):923-8. PubMed ID: 8227462
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.
Jones RN; Erwin ME
Antimicrob Agents Chemother; 1992 Jan; 36(1):233-8. PubMed ID: 1590695
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
Jones RN; Sanchez ML
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):61-8. PubMed ID: 8026159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]